10-Q: Mativ Holdings Reports Q2 Loss Amidst $412M Goodwill Impairment

Mativ Holdings, Inc. reported a significant net loss for the second quarter and first half of 2025, primarily driven by a substantial goodwill impairment charge in its Filtration & Advanced Materials segment.

Summary

• Net sales for the three months ended June 30, 2025, increased slightly by 0.3% to $525.4 million, while six-month net sales decreased by 1.3% to $1,010.2 million.
• The Filtration & Advanced Materials (FAM) segment's net sales decreased by 1.0% for the quarter and 4.2% for the six months, primarily due to lower selling prices and volume/mix.
• The Sustainable & Adhesive Solutions (SAS) segment's net sales increased by 1.1% for the quarter and 0.5% for the six months, driven by higher volume/mix and selling prices.
• Gross profit decreased by 4.8% to $103.7 million for the quarter and 8.6% to $176.3 million for the six months, impacted by higher manufacturing and distribution costs and unfavorable pricing versus input costs.
• Operating profit for the quarter increased to $20.1 million from $10.5 million in the prior year, but the six-month period saw an operating loss of $410.5 million, a significant decline from a $3.3 million loss in the prior year.
• A non-cash goodwill impairment charge of $411.9 million was recognized in the FAM segment during the first quarter of 2025 due to a sustained decline in the company's share price and an increased discount rate.
• Net loss for the quarter was $9.5 million, or $0.18 per diluted share, compared to a $1.4 million loss in the prior year. For the six months, net loss was $435.0 million, or $7.98 per diluted share, significantly higher than the $29.4 million loss in the prior year.
• Cash provided by operating activities increased to $41.7 million for the six months ended June 30, 2025, from $33.1 million in the prior year period.
• Total debt stood at $1,090.6 million as of June 30, 2025, with a net leverage ratio of 4.5x, below the maximum covenant ratio of 5.50x.
• The total debt to capital ratio increased to 72.4% as of June 30, 2025, from 55.9% at December 31, 2024.

Sentiment

Score: 2

Explanation: The sentiment is very negative due to the massive goodwill impairment charge leading to a substantial net loss and a significant increase in the debt-to-capital ratio. While some operational cost reductions were noted, the overall financial performance and outlook, particularly for the FAM segment, are concerning, indicating significant value destruction.

Positives

• Net sales for the Sustainable & Adhesive Solutions (SAS) segment showed growth for both the three-month (+1.1%) and six-month (+0.5%) periods, driven by higher volume/mix and selling prices.
• Operating profit for the three months ended June 30, 2025, increased significantly by 91.4% to $20.1 million compared to the prior-year quarter.
• Nonmanufacturing expenses decreased by 7.9% for the quarter and 3.1% for the six months, primarily due to cost-reduction actions under an organizational realignment initiative.
• Cash provided by operating activities increased to $41.7 million for the six months ended June 30, 2025, up from $33.1 million in the prior year, reflecting lower cash payments related to restructuring.
• The company remains in compliance with all financial covenants under its Credit Agreement and Indenture as of June 30, 2025.

Negatives

• A substantial non-cash goodwill impairment charge of $411.9 million was recorded in the Filtration & Advanced Materials (FAM) segment during the first quarter of 2025.
• The company reported a significant net loss of $435.0 million for the six months ended June 30, 2025, a substantial increase from the $29.4 million net loss in the prior year period.
• Diluted loss per share for the six months ended June 30, 2025, was $(7.98), a sharp increase from $(0.54) in the prior year.
• Gross profit declined by 4.8% for the quarter and 8.6% for the six months, impacted by higher manufacturing and distribution costs and unfavorable net selling price versus input cost performance.
• The FAM segment experienced a decrease in net sales and a significant operating loss for the six-month period due to the goodwill impairment and higher manufacturing costs.
• The total debt to capital ratio increased to 72.4% as of June 30, 2025, from 55.9% at December 31, 2024, indicating a higher leverage position.
• The weighted average effective interest rate on debt increased to approximately 7.42% for the six months ended June 30, 2025, from 6.10% in the prior year.

Risks

• Risks associated with the implementation of strategic growth initiatives, including diversification into new industries and technologies.
• Risks related to acquisitions, dispositions, strategic transactions, and global asset realignment initiatives.
• Adverse changes in end-market sectors impacting key customers.
• Changes in the source and intensity of competition in commercial end-markets.
• Adverse changes in sales or production volumes, pricing, and/or manufacturing costs.
• Seasonal or cyclical market and industry fluctuations leading to reduced net sales and operating profits.
• Risks that current technological advantages in intellectual property may not continue indefinitely.
• Supply chain disruptions, including the failure of material suppliers (energy, resin, fiber, chemicals).
• Increases in operating costs due to inflation and continuing increases in the inflation rate, such as labor expense, compensation, and benefits costs.
• Ability to attract and retain key personnel, labor shortages, labor strikes, stoppages, or other disruptions.
• Changes in general economic, financial, and credit conditions in the U.S., Europe, China, and elsewhere, including impacts on currency exchange rates and interest rates.
• Failure in risk management and/or currency or interest rate swaps and hedging programs, including failures of any insurance company or counterparty.
• Changes in the manner of financing debt and future capital needs, including potential acquisitions.
• Changes in tax rates, adoption of new U.S. or international tax legislation, or exposure to additional tax liabilities.
• Uncertainty as to the long-term value of the common stock.
• Changes in employment, wage, and hour laws and regulations, including unionization rules and anti-discrimination rules.
• The impact of tariffs, imposition of future additional tariffs, other trade barriers, retaliatory trade measures, and tariff uncertainty on macroeconomic conditions.
• Existing and future governmental regulation and enforcement that may materially restrict or adversely affect business and financial results.
• Weather conditions, including potential impacts from climate change, natural disasters, or unusual weather events.
• International conflicts and disputes, such as the ongoing conflict between Russia and Ukraine, and the war between Israel and Hamas, which restrict product supply due to demand effects, sanctions, or practical consequences on transportation and banking.
• Compliance with the FCPA and other anti-corruption laws or trade control laws.
• Risks associated with pandemics and other public health emergencies.
• The number, type, outcomes, and costs of legal, tax, regulatory, or administrative proceedings, litigation, and/or amnesty programs.
• Increased scrutiny from stakeholders related to environmental, social, and governance (ESG) matters, and the ability to achieve broader ESG goals.
• Costs and timing of implementation of any upgrades or changes to information technology systems.
• Failure to comply with privacy or data security laws or to protect against theft of sensitive information.
• Information technology system failures, data security breaches, network disruptions, and cybersecurity events.
• Potential future goodwill impairment charges for the SAS segment if factors like general economic conditions, market fluctuations, or adverse changes in end-market sectors negatively impact forecasted cash flows or if the share price declines further.

Future Outlook

The company expects to remain in compliance with financial covenants under its Amended Credit Agreement with current borrowing levels and forecasted results. Additional restructuring costs related to an ongoing facility closure in the FAM segment are not expected to exceed $1.0 million during the remainder of 2025. The company is evaluating the full effects of the recently signed 'One Big Beautiful Bill Act' on its estimated annual effective tax rate and cash tax position, but does not anticipate a material impact on its financial statements. The company will continue to assess its dividend policy in light of its overall strategy, cash generation, debt levels, and ongoing requirements for cash to fund operations and pursue strategic opportunities. The company acknowledges that its ability to achieve forecasted cash flows in the SAS segment may be negatively impacted by factors including general economic conditions, market fluctuations, adverse changes in end-market sectors, and the imposition of tariffs and other trade barriers, which could lead to future impairment charges.

Management Comments

• Management attributes the decrease in nonmanufacturing expenses to actions taken under an organizational realignment initiative aimed at streamlining organizational size and complexity and leveraging business-critical resources.
• The Chief Executive Officer and Chief Financial Officer have concluded that disclosure controls and procedures were effective as of June 30, 2025, and that the financial statements fairly present the financial condition, results of operations, and cash flows.
• Management believes that current sources of liquidity and capital, including cash on-hand, cash from operations, the Revolving Facility, and the Receivables Sales Agreement, will be sufficient to finance continued operations, current and long-term growth plans, and dividend payments.

Industry Context

The company operates in diverse end-markets, with the FAM segment serving generally high-growth areas like water and air purification, life sciences, and transportation, while the SAS segment serves both growing and mature end markets including building and construction, product packaging, and healthcare. The filing highlights the impact of broader macroeconomic conditions, including the uncertainty surrounding U.S. government tariffs and potential retaliatory tariffs from foreign governments, which could affect trading relationships and economic conditions in the markets where the company operates. The significant goodwill impairment in the FAM segment suggests challenges in achieving forecasted growth in its aligned end markets, potentially indicating a more competitive or slower-than-expected growth environment for advanced materials and filtration.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in various legal proceedings from time to time, including relating to contracts, commercial disputes, taxes, environmental issues, employment and workers' compensation claims, product liability, and other matters.
• Management believes that the ultimate disposition of these matters will not have a material effect on the results of operations in a given quarter or year.
• No material claims are pending under the $10 million indemnification related to the Engineered Papers business divestiture.

Stakeholder Impact

• Shareholders: Experienced a significant net loss and diluted loss per share due to the goodwill impairment, and a notable increase in the debt-to-capital ratio, potentially impacting share value. However, dividends continue to be paid.
• Employees: Subject to an organizational realignment initiative that has resulted in severance charges, indicating potential workforce adjustments.
• Creditors: The company remains in compliance with debt covenants, but the increased debt-to-capital ratio suggests higher financial leverage.
• Customers: The company continues to serve diverse and growing end markets, but the decline in FAM segment sales and the impact of tariffs could affect customer relationships and demand.

Next Steps

• Completion of additional initiatives under the organizational realignment plan through 2026, with the current initiative expected to be completed during 2025.
• Monitoring for advancements and further guidance in Pillar Two tax rules.
• Evaluation of the full effects of the 'One Big Beautiful Bill Act' on the estimated annual effective tax rate and cash tax position.
• Continued assessment of the dividend policy in light of overall strategy, cash generation, debt levels, and ongoing cash requirements for operations and strategic opportunities.
• Potential recording of additional restructuring costs in the FAM segment, not expected to exceed $1.0 million, related to an ongoing facility closure during the remainder of 2025.

Key Dates

Recommendation

The company reported a massive $411.9 million goodwill impairment charge, leading to a net loss of $435.0 million for the first half of 2025 and a diluted loss per share of $(7.98). This significant write-down, coupled with a substantial increase in the debt-to-capital ratio from 55.9% to 72.4%, indicates severe financial distress and a significant erosion of shareholder equity. While the company maintains compliance with debt covenants and has undertaken cost-reduction initiatives, the magnitude of the impairment and the overall negative financial performance suggest fundamental challenges and a high degree of uncertainty regarding future profitability and asset valuation. The increased effective interest rate on debt further pressures profitability. A seasoned investor would view these results as a strong signal to exit positions due to the significant capital destruction and potential for further downside.

Keywords

Specialty Materials, Filtration, Advanced Films, Tapes, Labels, Liners, Packaging, Healthcare Solutions, Goodwill Impairment, SEC Filing, Quarterly Report, Manufacturing, Industrial Materials, Financial Results